Error in Figure
In the original publication [1], there were copyright issues related to our Figures 1 and 2 as published in the previous version. Figure 1 was erroneously created without generating the “Confirmation of Publication and Licensing Rights” with BioRendering. Figure 2 was accidentally uploaded and used in our manuscript by our junior scientist. We were unaware that this previously published figure [2], was uploaded and unintentionally included in our published manuscript. We apologize to our colleagues for this inadvertent mistake. Figure 2 needs to be deleted from our paper because it belongs to the previously published paper: Amore, G.; Romagnoli, M.; Carbonelli, M.; Barboni, P.; Carelli, V.; La Morgia, C. Therapeutic Options in Hereditary Optic Neuropathies. Drugs 2021, 81, 57–86. https://doi.org/10.1007/s40265-020-01428-3. PMID: 33159657; PMCID: PMC7843467.
Two new figures have been generated to replace the previous ones in order to create “Confirmation of Publication and Licensing Rights” with BioRendering. These figures have been prepared as original graphic representations that have not been published in previous publications. Both updated original figures now have the proper licensing rights. The corrected Figure 1 and Figure 2 appear below. The scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Figure 1.
Summary of implicated proteins in LHON and DOA. Created in BioRender. Avitabile, A. (2025) https://BioRender.com/k6on15w (accessed on 6 September 2025).
Figure 2.
Different therapeutic approaches in hereditary optic neuropathies. Created in BioRender. Avitabile, A. (2025) https://BioRender.com/daxnqqg (accessed on 20 September 2025).
Footnotes
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
References
- 1.Zeppieri M., Gagliano C., Di Maita M., Avitabile A., Gagliano G., Dammino E., Tognetto D., Cordeiro M.F., D’Esposito F. Isolated and Syndromic Genetic Optic Neuropathies: A Review of Genetic and Phenotypic Heterogeneity. Int. J. Mol. Sci. 2025;26:3892. doi: 10.3390/ijms26083892. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Amore G., Romagnoli M., Carbonelli M., Barboni P., Carelli V., La Morgia C. Therapeutic Options in Hereditary Optic Neuropathies. Drugs. 2021;81:57–86. doi: 10.1007/s40265-020-01428-3. [DOI] [PMC free article] [PubMed] [Google Scholar]